Evoq Remedies Limited has notified BSE Limited of a rescheduling of its upcoming Board of Directors meeting. The meeting, originally scheduled for Thursday, May 14, 2026, at 4:00 P.M., has now been moved to Wednesday, May 27, 2026, at 4:00 P.M. The intimation was filed on May 11, 2026, pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will continue to be held at the company's registered office at A-1106, Empire Business Hub, Near AUDA Water Tank, Science City Road, Sola, Ahmedabad – 380 060.

Revised Board Meeting Details

The following table summarises the updated key details of the rescheduled board meeting:

Agenda for the Meeting

The Board of Directors will convene at the revised date to consider and approve the following items:

• Audited Financial Results of the company for the half year and year ended on March 31, 2026, along with the Auditor's Report
• Any other matter to be discussed and considered with the permission of the Chairperson of the Board Meeting

Authorised Signatory

The rescheduling intimation has been digitally signed and submitted by Bhumishth Patel, Managing Director of Evoq Remedies Limited (DIN: 02516641), and filed with BSE Limited on May 11, 2026.

Evoq remedies Limited has submitted its quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories and Participants) Regulations, 2018. The submission, dated April 9, 2026, covers the quarter ended March 31, 2026.

Regulatory Compliance Certificate

The company submitted the confirmation certificate received from M/s. Accurate Securities & Registry Private Limited, its appointed Registrar and Share Transfer Agent (RTA), as mandated under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Certificate Confirmation Details

Accurate Securities & Registry Private Limited confirmed that all securities received from depository participants for dematerialisation during the reporting period were processed within the stipulated time limits specified under SEBI regulations. The processing included either acceptance or rejection on technical grounds as applicable.

The RTA further certified that:

• Securities comprised in the certificates have been listed on stock exchanges where earlier issued securities are listed
• Securities received for dematerialisation have been mutilated/cancelled after due verification
• Depository names have been substituted in the security holder's list as registered owners within regulatory time limits

Corporate Information

Evoq Remedies Limited operates from its registered office located at A-1106, Empire Business Hub Near AUDA Water Tank, Science City Road, Sola, Ahmedabad, Gujarat. The compliance certificate was signed by Managing Director Bhumishth Patel, who holds DIN: 02516641.

RTA Service Details

Accurate Securities & Registry Private Limited, registered with SEBI under registration number INR000004173, serves as the company's share transfer agent. The RTA operates from Monday to Friday with call hours from 11:30 AM to 5:00 PM, maintaining a lunch break from 1:30 PM to 2:30 PM.

This quarterly compliance submission demonstrates Evoq Remedies Limited's commitment to maintaining regulatory adherence and transparent reporting practices as required under SEBI guidelines for listed companies.